Harry R Büller Selected Research

Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)

12/2020	Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases.
10/2020	Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis.
1/2020	The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.
2/2018	Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
10/2017	Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
10/2017	Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
8/2016	Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
11/2015	Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
1/2014	[Thromboprophylaxis in outpatients with cancer?].
6/2013	New developments in parenteral anticoagulation for arterial and venous thromboembolism.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harry R Büller Research Topics

Disease

74	Venous Thromboembolism 01/2022 - 03/2002
56	Hemorrhage 01/2022 - 07/2002
41	Pulmonary Embolism 01/2022 - 02/2002
38	Neoplasms (Cancer) 12/2021 - 09/2002
34	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 04/2002
20	Thrombosis (Thrombus) 06/2022 - 03/2002
6	Atrial Fibrillation 12/2020 - 09/2005
6	Stroke (Strokes) 12/2020 - 07/2011
6	Thrombophilia 01/2019 - 05/2009
5	Thromboembolism 06/2013 - 03/2005
4	COVID-19 12/2021 - 10/2020
4	Embolism (Embolus) 01/2019 - 02/2002
4	Body Weight (Weight, Body) 02/2018 - 10/2003
4	Cardiovascular Diseases (Cardiovascular Disease) 09/2015 - 05/2008
4	Acute Coronary Syndrome 06/2013 - 03/2002
4	Ischemic Stroke 07/2011 - 07/2002
4	Myocardial Infarction 05/2011 - 07/2002
4	Hyperhomocysteinemia 07/2008 - 10/2004
3	Inflammation (Inflammations) 01/2022 - 10/2005
3	Neoplasm Metastasis (Metastasis) 06/2021 - 04/2010
3	Heart Failure 12/2020 - 05/2011
3	Lung Neoplasms (Lung Cancer) 10/2020 - 11/2010
3	Hypertension (High Blood Pressure) 01/2017 - 07/2009
3	Thrombocytopenia (Thrombopenia) 01/2015 - 08/2011
3	Atherosclerosis 07/2009 - 07/2002
3	Sepsis (Septicemia) 10/2005 - 10/2002
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2021 - 08/2018
2	Infections 10/2020 - 11/2006
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019 - 01/2015
2	Diabetes Mellitus 09/2015 - 02/2012
2	Right Ventricular Dysfunction 10/2013 - 08/2004
2	Hemophilia A (Haemophilia) 02/2011 - 04/2005
2	Protein S Deficiency (Deficiency, Protein S) 05/2009 - 03/2005
2	Human Influenza (Influenza) 10/2007 - 11/2006
2	Endotoxemia 07/2006 - 10/2002
2	Activated Protein C Resistance (APC Resistance) 07/2006 - 02/2003
2	Peripheral Arterial Disease 03/2003 - 07/2002
1	HIV Infections (HIV Infection) 06/2022

Drug/Important Bio-Agent (IBA)

52	AnticoagulantsIBA 01/2022 - 02/2002
31	fibrin fragment D (D-dimer)IBA 01/2022 - 02/2002
27	Vitamin K FDA Link 01/2021 - 06/2003
25	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 03/2002
21	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 03/2002
19	Warfarin (Coumadin)FDA LinkGeneric 12/2020 - 06/2002
14	edoxabanIBA 12/2021 - 10/2013
14	Factor Xa InhibitorsIBA 01/2021 - 11/2002
11	Enoxaparin (Lovenox)FDA LinkGeneric 12/2021 - 08/2003
9	Protein CIBA 08/2011 - 07/2003
9	Factor VIII (Coagulation Factor VIII)IBA 02/2011 - 10/2002
8	Thrombin FDA Link 01/2020 - 03/2002
8	Prothrombin (Factor II)IBA 04/2011 - 07/2002
7	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 03/2002
6	AntithrombinsIBA 01/2019 - 10/2005
6	RivaroxabanIBA 01/2016 - 03/2007
5	Thromboplastin (Tissue Factor)IBA 01/2018 - 10/2002
5	Fondaparinux (Arixtra)FDA Link 06/2013 - 11/2002
5	factor V LeidenIBA 04/2011 - 03/2002
4	ORALIT (ORS)IBA 12/2021 - 10/2017
4	Factor XI (Plasma Thromboplastin Antecedent)IBA 12/2021 - 10/2002
4	CreatinineIBA 10/2021 - 10/2013
4	Factor Xa (Coagulation Factor Xa)IBA 01/2018 - 01/2012
4	Pharmaceutical PreparationsIBA 08/2016 - 03/2002
4	idraparinuxIBA 09/2015 - 03/2004
4	Protein SIBA 08/2011 - 03/2005
4	AntibodiesIBA 08/2011 - 03/2003
3	apixabanIBA 01/2019 - 11/2016
3	Dabigatran FDA Link 11/2016 - 09/2007
3	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2016 - 06/2010
3	AcenocoumarolIBA 09/2015 - 10/2005
3	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2013 - 11/2004
3	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 02/2013 - 10/2002
3	Hormones (Hormone)IBA 02/2011 - 07/2004
3	Nadroparin (Nadroparin Calcium)IBA 04/2010 - 04/2005
3	Factor VIIa (Activated Factor VII)IBA 07/2006 - 01/2003
3	recombinant FVIIa (rFVIIa)FDA Link 04/2005 - 11/2002
2	Immunoglobulin G (IgG)IBA 06/2022 - 03/2003
2	Hemoglobins (Hemoglobin)IBA 12/2021 - 10/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 04/2010
2	FibrinIBA 01/2018 - 11/2006
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2004
2	Blood Coagulation Factors (Coagulation Factor)IBA 08/2016 - 09/2012
2	Antisense OligonucleotidesIBA 01/2015 - 01/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2013 - 05/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2013 - 07/2004
2	GlucocorticoidsIBA 05/2013 - 08/2009
2	ProlactinIBA 09/2012 - 03/2011
2	Glucose (Dextrose)FDA LinkGeneric 02/2012 - 02/2011
2	Hemostatics (Antihemorrhagics)IBA 08/2009 - 07/2009
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2008 - 05/2004
2	HomocysteineIBA 08/2007 - 10/2004
1	Antiphospholipid AntibodiesIBA 06/2022

Therapy/Procedure

27	Therapeutics 06/2022 - 03/2002
9	Drug Therapy (Chemotherapy) 12/2021 - 11/2010
5	Duration of Therapy 01/2021 - 07/2003
3	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2021 - 02/2012
3	Central Venous Catheters 07/2020 - 09/2003
2	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2007 - 07/2002
2	Continuous Renal Replacement Therapy 07/2006 - 07/2003
2	Thrombolytic Therapy 11/2004 - 09/2004
2	Aftercare (After-Treatment) 06/2003 - 03/2002